Joel Greenblatt Viking Therapeutics, Inc. Transaction History
Gotham Asset Management, LLC
- $11.5 Billion
- Q1 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 24,500 shares of VKTX stock, worth $686,490. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,500Holding current value
$686,490% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
432Shares Held
65.2MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$285 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$169 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$114 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$87.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$87.4 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.15B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...